Tuesday 9 March 2021
الصفحة الرئيسية      كل الأخبار      اتصل بنا      RSS      English
bizbahrain - منذ 1 أشهر

Bahrain authorizes the emergency use of Oxford/AstraZeneca vaccine

The National Health Regulatory Authority (NHRA) approved the emergency use of the Oxford/AstraZeneca COVID-19 vaccine, manufactured by the Serum Institute of India under the name ‘Covishield’. The Oxford/AstraZeneca vaccine will support national efforts towards vaccinating vulnerable members of the public at risk of developing complications from COVID-19, including the elderly and people with chronic diseases, [ ]


آخر الأخبار
هشتک:   

Bahrain

 | 

authorizes

 | 

emergency

 | 

Oxford

 | 

AstraZeneca

 | 

vaccine

 | 

مصادر